🇦🇺 Australia Country × Condition
solid tumor Clinical Trials in Australia
Active clinical trials for solid tumor with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Enrollment
619 pts
Country
🇦🇺 Australia
Parabilis Medicines, Inc.
View Trial → NCT05786924 Phase 1, Phase 2
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Enrollment
554 pts
Country
🇦🇺 Australia
Institut de Recherches Internationa...
View Trial → NCT05269316 Phase 1, Phase 2
Recruiting
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Enrollment
61 pts
Country
🇦🇺 Australia
Impact Therapeutics, Inc.
View Trial → NCT06644300 Phase 1
Recruiting
Study of BM230 in Patients With Advanced Solid Tumors
Enrollment
123 pts
Country
🇦🇺 Australia
Suzhou Biomissile Pharmaceuticals C...
View Trial → NCT06536257
Recruiting
Personalised Immunotherapy Platform
Enrollment
1,000 pts
Country
🇦🇺 Australia
Melanoma Institute Australia
View Trial → Frequently Asked Questions
How many solid tumor clinical trials are active in Australia?
There are currently 5 active clinical trials for solid tumor with sites in Australia, of which 5 are actively recruiting patients.
How can I join a solid tumor clinical trial in Australia?
To join a solid tumor clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumor trials in Australia?
Active solid tumor trials in Australia span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology